Friday, 15 March 2019

Hemlibra Approved in Europe to Prevent Bleeds in Hemophilia A Patients Without Factor VIII Inhibitors - Hemophilia News Today

Hemlibra Approved in Europe to Prevent Bleeds in Hemophilia A Patients Without Factor VIII Inhibitors  Hemophilia News Today

The European Commission has approved the use of Hemlibra as prophylactic therapy for patients with severe hemophilia A without factor VIII inhibitors.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)